Literature DB >> 16545003

Recovery of genomic DNA from residual frozen archival blood clots suitable for amplification and use in genotyping assays.

David M Iovannisci1, Thanh T Ha, Gary M Shaw.   

Abstract

A greatly neglected source of DNA potentially useful for genetic or forensic studies is the clot remaining from blood samples collected for serum chemistry measurements. We have investigated the utility of residual clots remaining from venipunctures collected for California's Expanded Maternal Serum Alpha-Fetoprotein Screening Program. We report a protocol based on the salting out method for the extraction of DNA from samples which have been archived and frozen for up to 2.5 years. As much as 57 microg of high-quality DNA can be obtained from a 2-ml clot as determined by PicoGreen (Molecular Probes, Inc., Eugene, OR) fluorescence measurements. Quality of the purified DNA was evaluated by its ability to serve as template in polymerase chain reaction (PCR) amplifications, using primers that flank the polymorphic regions of six genes of pharmacogenetic interest distributed throughout the human genome. Sizes of the gene regions successfully amplified range from 215 bp to 2064 bp, using as little as 10 ng of template DNA. Because many genotyping protocols routinely recommend the design of amplicons in the 100-200 bp range, and 10-50 ng of template, we conclude that the clot remaining after serum has been removed from blood collected for serum chemistry measurements can serve as a reliable source of DNA for genotyping studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545003     DOI: 10.1089/gte.2006.10.44

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  6 in total

1.  Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.

Authors:  Kimberly Bunce; Tianjiao Chu; Urvashi Surti; William Allen Hogge; David G Peters
Journal:  Prenat Diagn       Date:  2012-04-11       Impact factor: 3.050

2.  Establishing a biologic specimens repository for reproductive clinical trials: technical aspects.

Authors:  Stephen A Krawetz; Peter R Casson; Michael P Diamond; Heping Zhang; Richard S Legro; William D Schlaff; Christos Coutifaris; Robert G Brzyski; Gregory M Christman; Nanette Santoro; Esther Eisenberg
Journal:  Syst Biol Reprod Med       Date:  2011-09-07       Impact factor: 3.061

3.  Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination.

Authors:  Alastair J Moss; Fiona P Gaughran; Aliyye Karasu; Anthony S Gilbert; Alex J Mann; Colin M Gelder; John S Oxford; Henry A Stephens; Rob Lambkin-Williams
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

4.  Structural and regulatory characterization of the placental epigenome at its maternal interface.

Authors:  Tianjiao Chu; Daniel Handley; Kimberly Bunce; Urvashi Surti; W Allen Hogge; David G Peters
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

5.  High-speed shaking of frozen blood clots for extraction of human and malaria parasite DNA.

Authors:  Klara Lundblom; Alex Macharia; Marianne Lebbad; Adan Mohammed; Anna Färnert
Journal:  Malar J       Date:  2011-08-08       Impact factor: 2.979

6.  Improved DNA extraction technique from clot for the diagnosis of Chagas disease.

Authors:  Holger Mayta; Yomara K Romero; Alejandra Pando; Manuela Verastegui; Freddy Tinajeros; Ricardo Bozo; Josephine Henderson-Frost; Rony Colanzi; Jorge Flores; Richard Lerner; Caryn Bern; Robert H Gilman
Journal:  PLoS Negl Trop Dis       Date:  2019-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.